Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
Submitted by
admin
on April 5, 2018 - 8:49am
Source:
CP Wire
News Tags:
Tenax Therapeutics
levosimendan
clinical trials
FDA
Headline:
FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
Do Not Allow Advertisers to Use My Personal information
